PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Year-End 2020 Financial Results

PTC Therapeutics将举办电话会议讨论2020年第四季度和年末财务结果

2021-02-12 05:00:13 BioSpace


 PTC Therapeutics, Inc.  today announced that the Company will host a webcast conference call to report its fourth quarter and year-end 2020 financial results and provide an update on the company's business and outlook on Thursday, February 25, 2021 at 4:30 p.m. after the closing of the market. The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 2174406. A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days following the call. About PTC Therapeutics, Inc. PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. For More Information Please Contact: Media & Investors:                                    Jane Baj                                                         +1 (908) 912-9167                             View original content: SOURCE PTC Therapeutics, Inc.
PTC Therapeutics,Inc.今天宣布,该公司将于2021年2月25日(星期四)下午4:30收盘后举行一次网络直播电话会议,报告其第四季度和2020年底的财务结果,并提供公司业务和展望的最新情况。 可在呼叫开始前5分钟拨打(877)303-9216(国内)或(973)935-8152(国际)并提供密码2174406接入呼叫。可在PTC网站的投资者关系部分(上访问电话会议的现场、仅供收听的网络直播。在通话结束后约两小时内,将对通话进行网络直播重播,并在通话后30天内在公司网站上存档。 PTC治疗公司简介。 PTC是一家以科学为驱动的全球性生物制药公司,专注于为罕见疾病患者提供益处的临床差异化药物的发现、开发和商业化。PTC在全球范围内实现产品商业化的能力是推动投资于强大和多样化的变革性药物管道的基础,也是我们为有未满足医疗需求的患者提供一流治疗的使命。 如需更多信息,请联系: 媒体和投资者: 简·巴伊 +1(908)912-9167 电子邮件 查看原文内容: 源PTC治疗公司。